drugset / Trial / NCT07165223
A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will be conducted to compare the efficacy, safety and patient-reported outcome of GZR4 and Insulin Icodec with or without Non-Insulin Antidiabetic Agents in subjects with Type 2 Diabetes Mellitus (T2DM) treated with basal insulin.
Timeline
- Start
- 2025-10-17
- Primary completion
- 2026-11-10
- Completion
- 2026-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GZR4 | Unknown | — | Subcutaneous |
| Comparator | Insulin icodec | Protein / enzyme biologic | — | Subcutaneous |